INNOGEN-B’s May 2026 Monthly Return Shows Stable Share Structure and Compliance With Public Float Rules

Bulletin Express06-03

Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for the period ended 31 May 2026, confirming that no changes occurred in either authorised or issued share capital during the month.

The company’s authorised share capital remained at 456.82 million RMB, comprising 420.29 million H-shares listed in Hong Kong and 36.53 million unlisted domestic shares, each with a par value of RMB 1.

Issued share capital was unchanged at 420.29 million H-shares and 36.53 million unlisted shares, with zero treasury shares outstanding. No share options, warrants, convertibles, or other equity instruments were issued, exercised, or cancelled in May 2026.

INNOGEN-B confirmed that its H-share public float continues to satisfy the Hong Kong Stock Exchange’s minimum 25 % requirement.

The Monthly Return was submitted on 3 June 2026 by Joint Company Secretary Yang Dongyan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134785093?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134785093","market":"hk","top_or_hot":-1,"title":"INNOGEN-B’s May 2026 Monthly Return Shows Stable Share Structure and Compliance With Public Float Rules","media":"Bulletin Express","content":"<p>Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for the period ended 31 May 2026, confirming that no changes occurred in either authorised or issued share capital during the month.</p>\n<p>The company’s authorised share capital remained at 456.82 million RMB, comprising 420.29 million H-shares listed in Hong Kong and 36.53 million unlisted domestic shares, each with a par value of RMB 1.</p>\n<p>Issued share capital was unchanged at 420.29 million H-shares and 36.53 million unlisted shares, with zero treasury shares outstanding. No share options, warrants, convertibles, or other equity instruments were issued, exercised, or cancelled in May 2026.</p>\n<p>INNOGEN-B confirmed that its H-share public float continues to satisfy the Hong Kong Stock Exchange’s minimum 25 % requirement.</p>\n<p>The Monthly Return was submitted on 3 June 2026 by Joint Company Secretary Yang Dongyan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INNOGEN-B’s May 2026 Monthly Return Shows Stable Share Structure and Compliance With Public Float Rules</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINNOGEN-B’s May 2026 Monthly Return Shows Stable Share Structure and Compliance With Public Float Rules\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for the period ended 31 May 2026, confirming that no changes occurred in either authorised or issued share capital during the month.</p>\n<p>The company’s authorised share capital remained at 456.82 million RMB, comprising 420.29 million H-shares listed in Hong Kong and 36.53 million unlisted domestic shares, each with a par value of RMB 1.</p>\n<p>Issued share capital was unchanged at 420.29 million H-shares and 36.53 million unlisted shares, with zero treasury shares outstanding. No share options, warrants, convertibles, or other equity instruments were issued, exercised, or cancelled in May 2026.</p>\n<p>INNOGEN-B confirmed that its H-share public float continues to satisfy the Hong Kong Stock Exchange’s minimum 25 % requirement.</p>\n<p>The Monthly Return was submitted on 3 June 2026 by Joint Company Secretary Yang Dongyan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02591","symbol_name":"银诺医药-B","start_time":0,"source_url":"","article_id":"1134785093","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134785093","pubTimestamp":1780478754,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for the period ended 31 May 2026, confirming that no changes occurred in either authorised or issued share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02591":"银诺医药-B"},"translate_title":"Innogen-B 2026年5月月报表显示股份结构稳定并符合公众持股量规则","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02591":1},"content_text":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for the period ended 31 May 2026, confirming that no changes occurred in either authorised or issued share capital during the month.\nThe company’s authorised share capital remained at 456.82 million RMB, comprising 420.29 million H-shares listed in Hong Kong and 36.53 million unlisted domestic shares, each with a par value of RMB 1.\nIssued share capital was unchanged at 420.29 million H-shares and 36.53 million unlisted shares, with zero treasury shares outstanding. No share options, warrants, convertibles, or other equity instruments were issued, exercised, or cancelled in May 2026.\nINNOGEN-B confirmed that its H-share public float continues to satisfy the Hong Kong Stock Exchange’s minimum 25 % requirement.\nThe Monthly Return was submitted on 3 June 2026 by Joint Company Secretary Yang Dongyan.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134785093","isCrawlerRequest":true}